| All Releases |
|---|
 |
Znomics and University of Utah Launch Collaborative Drug Discovery Program in Oncology, Autoimmune Disease and Inflammation
May 8, 2008
|
10.4 KB |
| |
PORTLAND, Ore., May 8, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today a collaborative research program with the University of Utah and its Huntsman Cancer Institute (HCI) to develop pre-clinical c...
|
|
Znomics CEO Richard Sessions to Speak At Pacific Northwest Life Sciences Meeting
May 6, 2008
|
8.3 KB |
| |
PORTLAND, Ore., May 6, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM) Chief Executive Officer Richard Sessions will speak today at the Pacific Northwest Life Sciences Meeting, being held in Portland, Oregon at The Benson Hotel.
Znomics, a pioneer in the development of the zebrafish as a vertebrate genetic platform to...
|
|
Znomics Launches Drug Discovery Program in Obesity Using Proprietary In Vivo Screening Model
Apr 15, 2008
|
9.4 KB |
| |
PORTLAND, Ore., Apr 15, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today the launch of a program to find lead drug compounds for the treatment of obesity.
Znomics obtained from Oregon Health & S...
|
|
Znomics Appoints Stephane Berghmans, D.V.M., Ph.D. to Director of Drug Discovery
Mar 6, 2008
|
9.4 KB |
| |
PORTLAND, Ore., Mar 6, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today the appointment of Stephane Berghmans, D.V.M., Ph.D. to Director of Drug Discovery, effective March 10, 2008.
Dr. Berghman...
|
|
Znomics Expands Drug Discovery Facilities
Feb 25, 2008
|
9.0 KB |
| |
PORTLAND, Ore., Feb 25, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, today said it has expanded its facilities to include additional laboratory space in the new Biomedical Research Building on the campus of Ore...
|
|
Znomics Promotes Stephen Kurtz, Ph.D. to Director of Operations
Feb 14, 2008
|
9.3 KB |
| |
PORTLAND, Ore., Feb 14, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today the promotion of Stephen Kurtz, Ph.D. to director of operations, effective March 1, 2008.
As director of operations, repo...
|
|
Znomics Retains James Posada as Business Advisor
Feb 12, 2008
|
9.7 KB |
| |
PORTLAND, Ore., Feb 12, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today that it has retained James Posada, Ph.D., as a business advisor to assist with business development, effective immediately.
...
|
|
Znomics Advances Drug Discovery Efforts in Zebrafish With Launch of New Human Disease Library
Feb 6, 2008
|
6.5 KB |
| |
PORTLAND, Ore., Feb 6, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, today announced it has achieved mutations in 193 key genes, representing nearly 50 percent of the known "druggable" disease genes. The company...
|
|
Znomics Appoints Thomas Scanlan, Professor of Pharmacology, to Scientific Advisory Board
Jan 23, 2008
|
6.3 KB |
| |
PORTLAND, Ore., Jan 23, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced the appointment of Thomas S. Scanlan, Ph.D., Director of the Chemical Biology Program at Oregon Health and Science University, to i...
|
|
Znomics, Inc. Begins Trading Under New Ticker Symbol -- ZNOM.OB
Jan 4, 2008
|
6.9 KB |
| |
PORTLAND, Ore., Jan 4, 2008 (PrimeNewswire via COMTEX News Network) -- Znomics, Inc., a pioneer in the development of the zebrafish as a simple vertebrate genetic platform to accelerate drug discovery, announced that its common stock will begin trading on the OTC Bulletin Board under the new ticker symbol, "ZNOM.OB", effective today, Friday, Januar...
|
|
Znomics, Inc. Completes $4.88 Million Financing and Merger with Public Company
Nov 27, 2007
|
8.4 KB |
| |
PORTLAND, Oregon (November 27, 2007) - Znomics, Inc., a pioneer in the development of the zebrafish as a simple vertebrate genetic platform to accelerate drug discovery, announced the successful closing on November 5, 2007 of a $4.88 million private offering. Simultaneously with the close of the private offering, the company effecte...
|
|
Kerry Rea Joins Znomics as Chief Financial Officer
Nov 12, 2007
|
3.5 KB |
| |
Kerry Rea, CPA...
|
|
ZeneMark® Library Milestone - Mutations in 11,000 Ensembl Annotated Genes
Oct 1, 2007
|
4.1 KB |
| |
Dr. Jianxin Wang, Znomics' Director of Bioinformatics, announced that the ZeneMark® Library achieved an important milestone, reaching mutations in 11,000 Ensembl annotated genes. Znomics has mapped more than 200,000 retroviral insertions on the zebrafish genome at this point. Dr. Wang indicated that a new appro...
|
|
Dr. David G. Ransom Joins Znomics as Director of Genetics and Functional Genomics
Aug 3, 2007
|
4.4 KB |
| |
David G. Ransom, Ph.D., joined Znomics in early July as the new Director of Genetics and Functional Genomics. He will provide leadership of the ZeneMark® Library, working closely with Dr. Jianxin Wang and Dr. Steve Kurtz. Dr. Greg Golling, who first developed the ZeneMark® ...
|
|
Merck and Znomics Enter into an Agreement for Drug Target Discovery on Metabolic Diseases
Dec 5, 2005
|
4.9 KB |
| |
*** Your Title Here ***
Portland, OR - Merck & Co., Inc. and Znomics, Inc. have entered into a collaborati...
|
| Showing 1-15 of 15 |
Page: 1 |
|
|
